Remote Patient Monitoring Market Updates

Remote Patient Monitoring Market size was valued at USD 24.3 billion in 2023 and is poised to grow from USD 28.92 billion in 2024 to USD 116.29 billion by 2032, growing at a CAGR of 19.0% during the forecast period (2025-2032).

Medtronic plc (US), Philips Healthcare (Netherlands), Boston Scientific Corporation (US), GE Healthcare (US), Abbott Laboratories (US), Omron Healthcare, Inc. (Japan), Honeywell International Inc. (US) , McKesson Corporation (US), Biotronik SE & Co. KG (Germany), Cisco Systems, Inc. (US), Bio-Beat (Israel), Nihon Kohden Corporation (Japan), Resideo Life Care Solutions (US), Masimo Corporation (US), iRhythm Technologies, Inc. (US), HEALTH BEATS (Singapore), STARLING MEDICAL (United States), ALIVE COR, INC. (United States), AKTIIA (Switzerland), TYTOCARE (United States), VIVALNK INC. (United States)

Growing adoption of Internet of Things (IoT) in remote monitoring devices is expected to drive market growth

The Adoption of RPM-enabled Home Health Monitoring Systems: Due in large part to the growing incidence of several chronic conditions among the senior population, RPM technology and home-based care are generating excellent returns for investors.

North America is the largest region in the remote patient monitoring market share of about 40.9%.